DB HiTek Completes Reliability Qualification for 8-Inch 1,200 V SiC MOSFET Process

DB HiTek Completes Reliability Qualification for 8-Inch 1,200 V SiC MOSFET Process

Establishes World's First Complete 8-Inch SiC Foundry Process Flow Provides First- and Second-Generation PDKs to Customers, with Third-Generation PDK Scheduled for November; Expected to Shorten Product Development Time by More Than One Year SEOUL,...

LX Pantos Successfully Completes Complex Defense Logistics Project for Advanced Weapons

LX Pantos Successfully Completes Complex Defense Logistics Project for Advanced Weapons

SEOUL, South Korea, Sept. 8, 2026 /PRNewswire/ -- LX Pantos (President & CEO: Lee Yong-ho) announced on September 8 that it had completed a cross-border defense logistics project for advanced weapons. The project transported air-to-air missiles...

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA on a New Drug Application (NDA) pathway in the U.S. that...

Bull Moose Tube Company Completes Acquisition of Hanna Steel Corporation

Bull Moose Tube Company Completes Acquisition of Hanna Steel Corporation

Transaction expands Bull Moose Tube's manufacturing footprint and strengthens its ability to serve customers across key end markets CHESTERFIELD, Mo., Sept. 1, 2026 /PRNewswire/ -- Bull Moose Tube Company ("Bull Moose"), a leading manufacturer of...

STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 People

STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 People

The renovated court at Communal Elementary School opens a dedicated space for learning, sport, and community life in Buhangin. DAVAO CITY, Philippines, Aug. 28, 2026 /PRNewswire/ -- STARCARES, the community impact initiative of STARTRADER, has...

eSign.AI Completes SOC 2 Type II Attestation, Strengthening Trust for Global Digital Transactions

eSign.AI Completes SOC 2 Type II Attestation, Strengthening Trust for Global Digital Transactions

Independent assessment validates the operating effectiveness of key security, availability and confidentiality controls supporting eSign.AI's global electronic signature and contract execution platform. HANGZHOU, China, Aug. 28, 2026 /PRNewswire/ --...

IBM Completes Acquisition of HRL Laboratories to Accelerate the Future of Quantum

IBM Completes Acquisition of HRL Laboratories to Accelerate the Future of Quantum

The combination brings together complementary expertise in quantum computing, sensing, materials science, and advanced technologies to accelerate future innovation ARMONK, N.Y., Aug. 26, 2026 /PRNewswire/ -- IBM (NYSE: IBM) today announced it has...

Metabolon Completes Landmark Global Health Pilot Advancing Women's and Infant Health

Metabolon Completes Landmark Global Health Pilot Advancing Women's and Infant Health

Innovative sample collection methods developed through Gates Foundation-funded grant enable high-quality metabolomics biomarker discovery in populations from low- and middle-income countries MORRISVILLE, N.C., Aug. 25, 2026 /PRNewswire/ --...

Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities

Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities

EAST RUTHERFORD, N.J., Aug. 25, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the successful completion of three Pre-Approval Inspections (PAIs) at its High Point, North...

Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027

Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027

TAIPEI, Aug. 25, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced that it has completed enrollment in its Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy in patients with advanced solid tumors harboring...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • menu
    menu